Scientists identify potential new biomarker to better personalize cancer therapy

Researchers from Duke-NUS Medical School, Erasmus University Medical Center, Yale-NUS College and Duke University have found a potential way to predict who will respond to cancer therapies that block Wnt production, such as the novel made-in-Singapore drug ETC-159. This discovery brings the goal of personalized medicine in cancer therapy a step closer to reality. Wnt […]

Continue Reading

The natural artistry of disease: A wintry landscape in the eye

Leukemias and lymphomas are life-threatening malignancies affecting white blood cells and the immune system; fortunately, radiotherapy and chemotherapy, combined with stem cell therapy, can improve survival significantly. Now, Japanese researchers report one such patient who presented with an intriguing and rare delayed ocular complication descriptively named frosted branch angiitis. A Japanese woman in her early […]

Continue Reading